# Safety and Tolerability Study of IV ST266 in COVID-19 Subjects

> **NCT04720378** · PHASE1 · COMPLETED · sponsor: **Noveome Biotherapeutics, formerly Stemnion** · enrollment: 12 (actual)

## Conditions studied

- Cytokine Release Syndrome

## Interventions

- **BIOLOGICAL:** ST266

## Key facts

- **NCT ID:** NCT04720378
- **Lead sponsor:** Noveome Biotherapeutics, formerly Stemnion
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-30
- **Primary completion:** 2022-05-03
- **Final completion:** 2022-05-03
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2022-06-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04720378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04720378, "Safety and Tolerability Study of IV ST266 in COVID-19 Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04720378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*